This study investigates the effects of an investigational medication on children who have glucocorticoid-induced osteoporosis (GiOP). Osteoporosis is a condition where bones become weak and brittle, and glucocorticoid-induced means it is caused by certain medications known as glucocorticoids.
Participants in this study will receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine. The study will monitor the effects on bone health.
- Who can participate: Children with a clinical diagnosis of glucocorticoid-induced osteoporosis are eligible to participate. For more detailed criteria, please contact the study team.
- Study details: Participants will be assigned to receive either the investigational medication or a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.

